MedPath
HSA Approval

DALACIN T TOPICAL GEL 1%

SIN09700P

DALACIN T TOPICAL GEL 1%

DALACIN T TOPICAL GEL 1%

April 6, 1998

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Therapeutic

Prescription Only

Formulation Information

GEL

**DOSAGE AND ADMINISTRATION** Apply a thin film of DALACIN T Topical Gel to the affected area of clean, dry skin twice daily. Massage into the skin is not needed. Contact with eyes and mouth should be avoided. Rinse hands after application.

TOPICAL

Medical Information

**INDICATIONS** DALACIN T Topical Gel is indicated in the treatment of acne vulgaris.

**CONTRAINDICATIONS** DALACIN T Topical Gel is contraindicated in individuals with a history of hypersensitivity to clindamycin or lincomycin, or a history of antibiotic-associated colitis.

D10AF01

clindamycin

Manufacturer Information

PFIZER PRIVATE LIMITED

Pharmacia & Upjohn Company LLC

Active Ingredients

CLINDAMYCIN PHOSPHATE EQV CLINDAMYCIN

1%

Clindamycin

Documents

Package Inserts

Dalacin Gel PI.pdf

Approved: January 30, 2019

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DALACIN T TOPICAL GEL 1% - HSA Approval | MedPath